|
|
|
NAFLD
https://www.ncbi.nlm.nih.gov/pubmed/31958476 NAFLD
Diabetes Res Clin Pract. 2020 Jan 17;160:108027. doi: 10.1016/j.diabres.2020.108027. [Epub ahead of print]
Fasting C-peptide is a significant indicator of nonalcoholic fatty liver disease in obese children.
Han X1, Xu P2, Zhou J1, Liu Y3, Xu H4.
Abstract
AIMS:
Whether fasting C-peptide can be a potential indicator for nonalcoholic fatty liver disease (NAFLD) in obese children is unknown. This study aimed to assess whether fasting C-peptide represented a risk factor for NAFLD.
METHODS:
https://pubmed.ncbi.nlm.nih.gov/33249617/ NAFLD
J Clin Lab Anal. 2020 Nov 28;e23602.
doi: 10.1002/jcla.23602. Online ahead of print.
Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity
Junfeng Zhang 1 2, Jiajia Cao 1 2, Hui Xu 1 2, Guanping Dong 2 3, Ke Huang 2 3, Wei Wu 2 3, Jingjing Ye 2 4, Junfen Fu 2 3
Abstract
Background: The association between serum ferritin and nonalcoholic fatty liver disease (NAFLD) in children with obesity is not clear. This study was designed to investigate whether serum ferritin can be an independent predictor for NAFLD.
https://www.ncbi.nlm.nih.gov/pubmed/30578461 NAFLD
Adv Exp Med Biol. 2018 Dec 22. doi: 10.1007/5584_2018_318. [Epub ahead of print]
Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT).
Nobili V1,2, Mosca A3, Alterio T3, Cardile S3, Putignani L4,5.
Abstract
https://pubmed.ncbi.nlm.nih.gov/33804296/ NAFLD
Review
J Clin Med. 2021 Mar 1;10(5):924.
doi: 10.3390/jcm10050924.
From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
Marta Flisiak-Jackiewicz 1, Anna Bobrus-Chociej 1, Natalia Wasilewska 1, Dariusz Marek Lebensztejn 1
Abstract
https://www.ncbi.nlm.nih.gov/pubmed/29470286 NAFLD
J Pediatr Gastroenterol Nutr. 2018 Feb 21. doi: 10.1097/MPG.0000000000001926. [Epub ahead of print]
Rausch JC, Lavine JE, Chalasani N, Guo X, Kwon S, Schwimmer JB, Molleston JP, Loomba R, Brunt EM, Chen YI, Goodarzi MO, Taylor KD, Yates KP, Rotter JI; NASH Clinical Research Network.
Abstract
BACKGROUND AND OBJECTIVES:
https://pubmed.ncbi.nlm.nih.gov/32381466/?from_term=children+AND+liver&f... NAFLD
J Pediatr.2020 May 4;S0022-3476(20)30392-9.
doi: 10.1016/j.jpeds.2020.03.038.Online ahead of print.
Glomerular Hyperfiltration Is Associated With Liver Disease Severity in Children With Nonalcoholic Fatty Liver Disease
Toshifumi Yodoshi 1, Ana Catalina Arce-Clachar 2, Qin Sun 3, Lin Fei 4, Kristin Bramlage 1, Stavra A Xanthakos 2, Francisco Flores 5, Marialena Mouzaki 6
Abstract
Objectives: To determine the prevalence of renal impairment in a large cohort of youths with histologically confirmed nonalcoholic fatty liver disease (NAFLD), and to determine its association with liver disease severity.
https://pubmed.ncbi.nlm.nih.gov/32381466/ NAFLD
J Pediatr. 2020 Jul;222:127-133.
doi: 10.1016/j.jpeds.2020.03.038. Epub 2020 May 4.
Glomerular Hyperfiltration Is Associated with Liver Disease Severity in Children with Nonalcoholic Fatty Liver Disease
Toshifumi Yodoshi 1, Ana Catalina Arce-Clachar 2, Qin Sun 3, Lin Fei 4, Kristin Bramlage 1, Stavra A Xanthakos 2, Francisco Flores 5, Marialena Mouzaki 6
PMID: 32381466
DOI: 10.1016/j.jpeds.2020.03.038
Abstract
Objectives: To determine the prevalence of renal impairment in a large cohort of youths with histologically confirmed nonalcoholic fatty liver disease (NAFLD), and to determine its association with liver disease severity.
https://www.ncbi.nlm.nih.gov/pubmed/27028797
Del Chierico F, Nobili V, Vernocchi P, Russo A, Stefanis C, Gnani D, Furlanello C, Zandonà A, Paci P, Capuani G, Dallapiccola B, Miccheli A, Alisi A, Putignani L.
Hepatology. 2017 Feb;65(2):451-464. doi: 10.1002/hep.28572.
Abstract
https://www.ncbi.nlm.nih.gov/pubmed/28767077
Children (Basel). 2017 Aug 2;4(8). pii: E66. doi: 10.3390/children4080066.
.
Poeta M1,2, Pierri L3,4, Vajro P5,6.
Author information
Abstract
http://www.ncbi.nlm.nih.gov/pubmed/25522307
Shang XR, Song JY, Liu FH, Ma J, Wang HJ. GWAS-Identified Common Variants With Nonalcoholic Fatty Liver Disease in Chinese Children. J Pediatr Gastroenterol Nutr. 2015 May; 60(5):669-74.
Abstract
OBJECTIVES:
Three genome-wide association studies were previously done for nonalcoholic fatty liver disease (NAFLD) among individuals of Western countries and identified several genetic variants associated with NAFLD. The study aimed to identify whether 7 GWAS-identified common variants (GCKR rs780094, PDGFA rs343064, FDFT1 rs2645424, COL13A1 rs1227756, EHBP1L1 rs6591182, NCAN rs2228603, and PNPLA3 rs738409) were associated with NAFLD in Chinese children.
METHODS:
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
